Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
71,313,910
-
Share change
-
+1,312,835
-
Total reported value
-
$1,187,570,279
-
Put/Call ratio
-
273%
-
Price per share
-
$16.65
-
Number of holders
-
125
-
Value change
-
+$24,922,269
-
Number of buys
-
58
-
Number of sells
-
66
Institutional Holders of ALDER BIOPHARMACEUTICALS INC - COM (ALDR) as of Q3 2018
As of 30 Sep 2018,
ALDER BIOPHARMACEUTICALS INC - COM (ALDR) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,313,910 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, Redmile Group, LLC, Vanguard Group Inc, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Foresite Capital Management III, LLC, CITADEL ADVISORS LLC, BB BIOTECH AG, and FMR LLC.
This page lists
125
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.